慢性肾脏疾病和癌症风险:个体参与者数据荟萃分析

IF 6.8 1区 医学 Q1 ONCOLOGY
Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees
{"title":"慢性肾脏疾病和癌症风险:个体参与者数据荟萃分析","authors":"Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees","doi":"10.1038/s41416-025-03140-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.</p><p><strong>Methods: </strong>This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.</p><p><strong>Results: </strong>Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.</p><p><strong>Discussion: </strong>Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.</p>","PeriodicalId":9243,"journal":{"name":"British Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.\",\"authors\":\"Yejin Mok, Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E Grams, Kunihiro Matsushita, Shoshana H Ballew, Natalia Alencar de Pinho, Johan Ärnlöv, Sandhi M Barreto, Samira Bell, Hermann Brenner, Juan-Jesus Carrero, Rajkumar Chinnadurai, Elizabeth Ciemins, Ron T Gansevoort, Simerjot K Jassal, Keum Ji Jung, H Lester Kirchner, Tsuneo Konta, Csaba P Kovesdy, Li Luo, Krutika Pandit, Mahboob Rahman, Cassianne Robinson-Cohen, Charumathi Sabanayagam, Ulla T Schultheiss, Michael Shlipak, Natalie Staplin, Marcello Tonelli, Angela Yee-Moon Wang, Chi-Pang Wen, Mark Woodward, Jennifer S Lees\",\"doi\":\"10.1038/s41416-025-03140-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.</p><p><strong>Methods: </strong>This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.</p><p><strong>Results: </strong>Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.</p><p><strong>Discussion: </strong>Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.</p>\",\"PeriodicalId\":9243,\"journal\":{\"name\":\"British Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-09-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41416-025-03140-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41416-025-03140-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:研究慢性肾脏疾病(CKD)与癌症风险的关系已经证明了相互矛盾的结果。方法:这是一项个体参与者数据荟萃分析,包括54个国际队列,为CKD预后协会做出贡献。纳入的队列有蛋白尿[尿白蛋白与肌酐比值(ACR)]、肾小球滤过率(eGFR)、总体和部位特异性癌症发病率以及确定的癌症危险因素的数据。纳入的参与者年龄在18岁或以上,以前没有癌症或肾衰竭。结果:在1319308名患者中,总体癌症发病率为17.3 / 1000人年。较高的ACR与癌症风险呈正相关[校正风险比为1.08 (95% CI 1.06-1.10) / ACR增加8倍]。eGFR与总体癌症风险没有关联。对于特定部位的癌症,较低的eGFR与泌尿系统癌和多发性骨髓瘤有关,而较高的ACR与许多类型的癌症(肾癌、头颈癌、结直肠癌、肝癌、胰腺癌、胆管癌、胃癌、喉癌、肺癌、血淋巴癌、白血病和多发性骨髓瘤)有关。1年里程碑分析的结果相似。讨论:蛋白尿,但不一定是eGFR,与随后的癌症风险独立相关。我们的结果保证了对解释蛋白尿和癌症之间联系的机制的调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis.

Background: Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results.

Methods: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure.

Results: Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis.

Discussion: Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
British Journal of Cancer
British Journal of Cancer 医学-肿瘤学
CiteScore
15.10
自引率
1.10%
发文量
383
审稿时长
6 months
期刊介绍: The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research.It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信